Related Experiment Videos
Risk factors for proliferative sickle retinopathy
P D Fox1, D T Dunn, J S Morris
1Medical Research Council Laboratories, University of the West Indies, Kingston, Jamaica.
The British Journal of Ophthalmology
|March 1, 1990
Summary
Proliferative sickle retinopathy (PSR) is more common in sickle cell haemoglobin C (SC) disease than in sickle cell (SS) disease, affecting males more and increasing with age. Haematological factors like fetal haemoglobin levels influence PSR risk.
Area of Science:
- Ophthalmology
- Hematology
- Genetics
Background:
- Sickle cell retinopathy, particularly proliferative sickle retinopathy (PSR), is a significant complication of sickle cell disease.
- Understanding the prevalence, incidence, and risk factors for PSR is crucial for patient management and preventative strategies.
Purpose of the Study:
- To investigate the prevalence, incidence, and risk factors of proliferative sickle retinopathy (PSR) in patients with homozygous sickle cell (SS) disease and sickle cell haemoglobin C (SC) disease.
- To identify demographic and hematological factors associated with PSR development in these patient groups.
Main Methods:
- Retrospective analysis of 786 patients with SS disease and 533 patients with SC disease.
- Assessment of PSR prevalence, incidence, and associated risk factors, including age, sex, and hematological parameters.
Main Results:
- PSR was more prevalent in SC disease (predominantly in males) and increased with age in both genotypes.
- Age-specific risk peaks for PSR were identified: 15-24 years (males) and 20-39 years (females) in SC disease; 25-39 years (both sexes) in SS disease.
- Hematological risk factors included high hemoglobin in males and low fetal hemoglobin in both sexes for SS disease, and high mean cell volume and low fetal hemoglobin in females for SC disease.
Conclusions:
- Proliferative sickle retinopathy (PSR) is more common in SC disease, with distinct age and sex risk profiles.
- Specific hematological parameters are associated with PSR risk in both SS and SC disease, highlighting potential targets for intervention.